From the *Robert Wood Johnson Clinical Scholars Program, The Johns Hopkins University School of Medicine, Baltimore, Maryland; †Outcomes Research Department, Eli Lilly and Company, Indianapolis, Indiana; ‡Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins University, Baltimore, Maryland; the §Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and the ∥Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Dr. Powe was supported by grant number K24DK02643 from the National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland. Dr. Cooper was supported by a grant from the Commonwealth Fund.
Dr. Kinchen was a fellow in the Robert Wood Johnson Clinical Scholars Program during the time this work was conducted. He is presently employed by Eli Lilly and Company, which has no role or financial interest in this study.
Reprints: Neil R. Powe, MD, MPH, MBA, Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins Medical Institutions, 2024 East Monument Street, Suite 2-600, Baltimore, MD 21205-2223. E-mail: [email protected].